Healthways, Inc. (TVTY) Receives Consensus Recommendation of “Buy” from Analysts
Healthways, Inc. (NASDAQ:TVTY) has been given an average recommendation of “Buy” by the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $32.83.
Several analysts recently weighed in on TVTY shares. Zacks Investment Research upgraded Healthways from a “hold” rating to a “buy” rating and set a $32.00 price target on the stock in a research note on Wednesday, April 26th. Cantor Fitzgerald restated a “buy” rating and issued a $32.00 price target on shares of Healthways in a research note on Friday, February 24th. Jefferies Group LLC restated a “buy” rating and issued a $33.00 price target on shares of Healthways in a research note on Friday, February 24th. SunTrust Banks, Inc. started coverage on Healthways in a research note on Wednesday, March 15th. They issued a “buy” rating and a $35.00 price target on the stock. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $41.00 price target (up previously from $32.00) on shares of Healthways in a research note on Monday, May 1st.
Healthways (TVTY) remained flat at $37.50 on Tuesday. 87,555 shares of the company traded hands. The firm has a 50-day moving average of $33.39 and a 200 day moving average of $27.78. The firm’s market capitalization is $1.47 billion. Healthways has a 1-year low of $11.15 and a 1-year high of $40.00.
Healthways (NASDAQ:TVTY) last posted its quarterly earnings results on Thursday, April 27th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.08. The company had revenue of $141 million for the quarter, compared to the consensus estimate of $136.28 million. Healthways had a positive return on equity of 37.59% and a negative net margin of 18.90%. The business’s revenue was up 11.9% compared to the same quarter last year. Equities research analysts anticipate that Healthways will post $1.55 earnings per share for the current fiscal year.
In related news, Director Mary Jane England sold 1,763 shares of the company’s stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $31.95, for a total value of $56,327.85. Following the transaction, the director now directly owns 19,453 shares of the company’s stock, valued at approximately $621,523.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 8.42% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue acquired a new position in Healthways during the first quarter valued at about $107,000. ClariVest Asset Management LLC acquired a new position in Healthways during the first quarter valued at about $141,000. US Bancorp DE acquired a new position in Healthways during the first quarter valued at about $145,000. Strs Ohio acquired a new position in Healthways during the first quarter valued at about $154,000. Finally, Capstone Asset Management Co. acquired a new position in Healthways during the first quarter valued at about $216,000.
Healthways Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.